# Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer

> **NCT01194531** · PHASE4 · TERMINATED · sponsor: **Natera, Inc.** · enrollment: 59 (actual)

## Conditions studied

- Preimplantation Gentic Screening (PGS)
- In Vitro Fertilization (IVF)
- Preimplantation Genetic Diagnosis (PGD)

## Interventions

- **DEVICE:** 24 Chromosome Aneuploidy Screening with Parental Support

## Key facts

- **NCT ID:** NCT01194531
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Slow enrollment and Natera is transitioning to a new PGS testing platform.
- **Last updated:** 2014-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01194531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01194531, "Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01194531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*